TALPHERA, INC. Operating Lease Cost
TALPHERA, INC. (TLPH) reported Operating Lease Cost of $200.00 thousand for the 12-month period ending 2022-12-31, per its 8-K filed 2023-08-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2023-08-01
- TALPHERA, INC. operating lease, cost for the quarter ending 2022-12-31 was -$830.00K.
- TALPHERA, INC. operating lease, cost for the quarter ending 2022-09-30 was $344.00K, a 0.29% increase year-over-year.
- TALPHERA, INC. operating lease, cost for the quarter ending 2022-06-30 was $343.00K, a 22.05% decline year-over-year.
- TALPHERA, INC. operating lease, cost for the quarter ending 2022-03-31 was $343.00K, a 0.88% increase year-over-year.
- TALPHERA, INC. operating lease, cost for fiscal 2020 was $1.36M, a 0.00% change from fiscal 2019.
- TALPHERA, INC. operating lease, cost for fiscal 2019 was $1.36M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 6 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month | Operating Lease, Cost 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | -$830.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -$486.00K derived: sum of 2 quarters · filed 2023-08-01 | -$143.00K derived: sum of 3 quarters · filed 2023-08-01 | $200.00K 8-K · filed 2023-08-01 | $1.37M 10-K · filed 2023-03-31 |
| 2022-09-30 | $344.00K 10-Q · filed 2022-11-14 | $687.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.03M 10-Q · filed 2022-11-14 | $444.00K derived: sum of 4 quarters · filed 2023-08-01 | |
| 2022-06-30 | $343.00K 10-Q · filed 2022-08-11 | $686.00K 10-Q · filed 2022-08-11 | $100.00K derived: sum of 3 quarters · filed 2023-08-01 | $443.00K derived: sum of 4 quarters · filed 2023-08-01 | |
| 2022-03-31 | $343.00K 10-Q · filed 2022-05-16 | -$243.00K derived: sum of 2 quarters · filed 2023-08-01 | $100.00K derived: sum of 3 quarters · filed 2023-08-01 | $540.00K derived: sum of 4 quarters · filed 2023-08-01 | |
| 2021-12-31 | -$586.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-08-01 | -$243.00K derived: sum of 2 quarters · filed 2023-08-01 | $197.00K derived: sum of 3 quarters · filed 2023-08-01 | $537.00K 8-K · filed 2023-08-01 | $1.47M 10-K · filed 2022-03-10 |
| 2021-09-30 | $343.00K 10-Q · filed 2022-11-14 | $783.00K derived: sum of 2 quarters · filed 2022-11-14 | $1.12M 10-Q · filed 2022-11-14 | $1.57M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $440.00K 10-Q · filed 2022-08-11 | $780.00K 10-Q · filed 2022-08-11 | $1.23M derived: sum of 3 quarters · filed 2022-08-11 | $1.53M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $340.00K 10-Q · filed 2022-05-16 | $786.00K derived: sum of 2 quarters · filed 2022-05-16 | $1.09M derived: sum of 3 quarters · filed 2022-05-16 | $1.36M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $751.00K derived: sum of 2 quarters · filed 2022-03-10 | $1.02M derived: sum of 3 quarters · filed 2022-03-10 | $1.36M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $305.00K 10-Q · filed 2021-11-15 | $574.00K derived: sum of 2 quarters · filed 2021-11-15 | $914.00K 10-Q · filed 2021-11-15 | $1.25M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $269.00K 10-Q · filed 2021-08-16 | $609.00K 10-Q · filed 2021-08-16 | $949.00K derived: sum of 3 quarters · filed 2021-08-16 | $1.29M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $340.00K 10-Q · filed 2021-05-17 | $680.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.02M derived: sum of 3 quarters · filed 2021-05-17 | $1.36M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $340.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $680.00K derived: sum of 2 quarters · filed 2021-03-15 | $1.02M derived: sum of 3 quarters · filed 2021-03-15 | $1.36M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $340.00K 10-Q · filed 2020-11-05 | $680.00K derived: sum of 2 quarters · filed 2020-11-05 | $1.02M 10-Q · filed 2020-11-05 | ||
| 2019-06-30 | $340.00K 10-Q · filed 2020-08-10 | $680.00K 10-Q · filed 2020-08-10 | |||
| 2019-03-31 | $340.00K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |